Skip to Content

Join the 'Cervical Dysplasia' group to help and get support from people like you.

Cervical Dysplasia News

Related terms: Dysplasia, Precancerous changes of the cervix

Pubic Grooming Tied to Higher STD Rates

Posted 1 day 14 hours ago by Drugs.com

MONDAY, Dec. 5, 2016 – Brazilian bikini waxing and similar forms of personal grooming may be all the rage, but they come with a heightened risk of acquiring a sexually transmitted disease, new research suggests. The study found that frequent groomers of pubic hair are three to four times more likely to contract a sexually transmitted infection, such as herpes, human papillomavirus (HPV) or syphilis. "Grooming is linked to a heightened self-reported sexually transmitted disease risk, and for those who groom frequently or remove all of their hair often, the association is even higher," said lead researcher Dr. Charles Osterberg. He's an assistant professor of urology and surgery at the University of Texas Dell Medical School in Austin. Still, the study didn't prove a direct cause-and-effect relationship between pubic grooming and sexually transmitted infections, it was only designed to ... Read more

Related support groups: Sexually Transmitted Diseases, Cold sores, Herpes Simplex - Suppression, Herpes Simplex, Human Papilloma Virus, Syphilis, Herpes Simplex Labialis, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Cervical Dysplasia, Tertiary Syphilis, Syphilis - Early, Neurosyphilis, Human Papillomavirus Prophylaxis, Herpes Simplex - Prophylaxis, Syphilis - Latent

2 Doses of HPV Vaccine Effective for Younger Teens

Posted 15 days ago by Drugs.com

TUESDAY, Nov. 22, 2016 – New global research confirms that two doses of the vaccine for HPV, rather than three, can protect younger teens against the sexually transmitted virus. Based on this study and others, U.S. government health officials revised their guidelines last month to recommend a two-dose regimen for teens younger than 15. Prior to that revised guideline, three doses were recommended for adolescents and young adults up through 26 years of age. The vaccine protects against infection by HPV (human papillomavirus), which is the cause of 90 percent of cervical cancers, according to the U.S. National Cancer Institute. The new review included more than 1,500 young people, aged 9 to 26, who were vaccinated against HPV at 52 sites in 15 countries. For the study, the researchers gave two doses of HPV vaccine to teens aged 9 to 14, and three doses of the vaccine to older teens and ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Anal Cancer Rates Rising in Many Parts of the World

Posted 2 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 2, 2016 – Anal cancer rates are on the rise in many countries. But vaccination against human papillomavirus (HPV) – a virus linked to the development of anal cancer – may help curb rates of the disease, a new study suggests. Researchers looked at data from the International Agency for Research on Cancer. The data included 18 countries. The investigators found that anal cancer rates have been increasing in women and men in 13 of those countries, particularly Australia and other countries in the Americas, and northern and western Europe. In those countries, a major subtype called anal squamous cell carcinoma (ASCC) was much more common than others, and was the main reason for the overall increasing rates of anal cancer. Rates of another major subtype, anal adenocarcinoma (AAC), have been stable or decreasing in most populations, the researchers said. "The reason for the ... Read more

Related support groups: Cancer, Colorectal Cancer, Human Papilloma Virus, Anal Fissure and Fistula, Condylomata Acuminata, Anal Itching, Gardasil, Cervical Dysplasia, Human Papillomavirus Vaccine, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

Kids 14 and Younger Only Need 2 HPV Vaccine Shots: CDC

Posted 20 Oct 2016 by Drugs.com

THURSDAY, Oct. 20, 2016 – Children 14 and younger require only two doses of the HPV vaccine rather than the previously recommended three shots, U.S. health officials now say. The vaccine protects against infection with sexually transmitted HPV (human papillomavirus), which can cause cervical and other cancers. On Wednesday, the Centers for Disease Control and Prevention recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart. It also said teens 13 and 14 can be vaccinated on the two-dose schedule. However, those who start receiving the vaccinations later – at ages 15 to 26 – still need three doses of the vaccine, according to the updated guidelines. One cervical cancer expert called the new guidelines "very important." "Decreasing the number of shots from three to two will definitely increase the chances of compliance [with vaccination]," said ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Vaccination and Prophlaxis, Gardasil 9

Are Fewer Cervical Cancer Screenings Needed After HPV Vaccine?

Posted 18 Oct 2016 by Drugs.com

MONDAY, Oct. 17, 2016 – Women who've been vaccinated against human papillomavirus (HPV) likely need fewer cervical cancer screenings, a new study argues. Just how often a woman needs a cervical cancer screening depends on the type of vaccine she had, the researchers said. Women vaccinated with earlier versions of the HPV vaccine – which protect against the two worst cancer-causing strains of the sexually transmitted virus – only need cervical cancer screening every five years starting at age 25 or 30, the study concluded. Women who've received the updated vaccine, which protects against seven cancer-causing strains of HPV, need screening even less often. The researchers recommend testing these women every 10 years starting at age 30 to 35 and ending at age 65. Both screening regimens would be much less rigorous than current guidelines, which call for cervical cancer exams from age 21 ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Gardasil 9

How One Clinic Got a Big Boost in HPV Vaccination Rates

Posted 5 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 5, 2016 – The way to increase the number of girls and boys who get the human papillomavirus (HPV) vaccine may be as simple as giving it as part of a routine bundle of vaccines, a new study suggests. The HPV vaccine, which guards against the virus that causes most cervical cancers, is only being used in just over half of teen girls in the United States, lagging far behind other recommended vaccinations in this age group. But, by lumping HPV in with other required vaccinations, a Denver clinic was able to dramatically increase vaccination rates to nearly 90 percent in boys and girls, researchers report. "The program is simple and low cost, and something that can easily be rolled out at other institutions," said lead researcher Dr. Anna-Lisa Farmar. She is an assistant professor of pediatrics at the University of Colorado in Aurora. "It's become a part of our general ... Read more

Related support groups: Human Papilloma Virus, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

A Doctor's Words Key to Whether Child Gets HPV Vaccine

Posted 2 Oct 2016 by Drugs.com

FRIDAY, Sept. 30, 2016 – The language doctors use when recommending the human papillomavirus (HPV) vaccine can influence whether parents will have their children immunized, a new study finds. HPV causes most cases of cervical cancer and a large percentage of vaginal, vulvar, anal, penile and oropharyngeal cancers. The U.S. Centers for Disease Control and Prevention recommends boys and girls receive the three-dose HPV vaccination beginning at age 11 or 12. As of 2015, only 42 percent of girls and 28 percent of boys ages 13 to 17 had completed the HPV vaccine series, according to the CDC. Previous research found that doctors' recommendations play a major role in whether parents have their children vaccinated. In this new study, researchers examined if specific language used by doctors affects parents' decisions. The study included more than 1,500 parents. Their children were between the ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Head and Neck Cancer, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Cancer Experts Endorse CDC's HPV Vaccine Guidelines

Posted 19 Jul 2016 by Drugs.com

TUESDAY, July 19, 2016 – The American Cancer Society has endorsed the U.S. government's HPV vaccination recommendations, which include immunizing all preteens against the sexually transmitted human papilloma virus. In a new report, the cancer society says 11- and 12-year-old girls as well as boys should be vaccinated to guard against cancers associated with HPV. This is in line with updated guidelines from the federal Centers for Disease Control and Prevention. "HPV vaccination has the potential to prevent tens of thousands of cancers and hundreds of thousands of pre-cancers each year," said the lead author of the report, Debbie Saslow. She is the cancer society's director of cancer control intervention for HPV vaccination and women's cancers. "It is critical that all stakeholders – families, health care providers, and others – make HPV vaccination a priority, so that prevention of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

1st HPV Test for Use With Preservative Fluid

Posted 8 Jul 2016 by Drugs.com

FRIDAY, July 8, 2016 – The U.S. Food and Drug Administration has approved Roche's cobas HPV Test – the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid. SurePath is an FDA-approved liquid collection fluid that's frequently used for Pap tests. But until this latest approval, no human papillomavirus (HPV) test had been approved to be used with the fluid, the FDA said in a news release. HPV strains account for some 70 percent of cervical cancers globally. The U.S. National Cancer Institute estimates there will be nearly 13,000 new cases of cervical cancer detected this year, and the disease will cause more than 4,100 deaths. The Swiss drugmaker Roche in 2012 warned that using cervical cells in SurePath fluid with an existing HPV test could produce false-negative results, the FDA said. This could have led to lack of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Diagnosis and Investigation, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Gardasil 9

Study Hints at HPV Vaccine's Cancer Prevention Promise

Posted 5 Jul 2016 by Drugs.com

MONDAY, July 4, 2016 – The human papillomavirus (HPV) vaccine appears to prevent abnormalities that can lead to cervical cancer, a new study shows. Canadian researchers found that young women who received the vaccine through a school-based program were less likely to have such abnormalities when screened for cervical cancer than those who did not receive the vaccine. The young women were screened less than 10 years after they received their first HPV vaccine. The findings are from the province of Alberta. In 2008, Alberta introduced HPV vaccination for grade 5 girls (aged 10-11) and a three-year catch-up program for grade 9 girls (aged 14-15). The program provided three doses of the vaccine that protects against two strains of HPV. Those two strains of HPV account for 70 percent of all cases of cervical cancer, the researchers said. The study evaluated Pap test results for more than ... Read more

Related support groups: Human Papilloma Virus, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

HPV Vaccine Rates Highest in Poor and Hispanic Communities: Study

Posted 14 Jan 2016 by Drugs.com

THURSDAY, Jan. 14, 2016 – Teen girls in poor or predominately Hispanic communities are more likely to receive at least one dose of the human papillomavirus (HPV) vaccine than those in other communities, a new study finds. HPV can cause cancers of the cervix, vulva, vagina, anus, penis and throat, and the U.S. Centers for Disease Control and Prevention recommends that all girls and boys aged 11 to 12 receive three doses of the HPV vaccine. Researchers examined 2011 and 2012 CDC data on provider-verified vaccination records for more than 20,500 girls, aged 13 to 17. In each of those years, 53 percent of the girls received at least one dose of HPV vaccine. The highest vaccination initiation rate (69 percent) was among girls in predominately Hispanic communities and the lowest rates were among girls in predominately black communities (54 percent) and white communities (50 percent). Poverty ... Read more

Related support groups: Cancer, Human Papilloma Virus, Cervical Cancer, Gardasil, Head and Neck Cancer, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Too Few Preteen Girls Get HPV Vaccine, CDC Says

Posted 29 Oct 2015 by Drugs.com

THURSDAY, Oct. 29, 2015 – HPV vaccination rates among American girls remain too low, a new U.S. government study says. The vaccine protects against infection with the sexually transmitted human papillomavirus (HPV), which can cause cancers of the cervix, vulva, vagina and anus. "Increasing delivery of HPV vaccination at the recommended ages of 11 or 12 years, before most adolescents are exposed to the virus, can ensure adolescents are protected against HPV infections and associated cancers," according to the report from the U.S. Centers for Disease Control and Prevention. Researchers from the CDC and the National Committee for Quality Assurance analyzed vaccination data on more than 626,000 girls at age 13 enrolled in either private insurance plans or Medicaid in 2013. All three doses of HPV vaccine were given to a median of 12 percent of privately insured girls and 19 percent of those ... Read more

Related support groups: Human Papilloma Virus, Gardasil, Cervarix, Human Papillomavirus Vaccine, Cervical Dysplasia, Human Papillomavirus Prophylaxis, Gardasil 9

Too Few U.S. Teens Getting HPV Vaccine: CDC

Posted 30 Jul 2015 by Drugs.com

THURSDAY, July 30, 2015 – Most boys and a large portion of girls in the United States have not received even a single dose of the cancer-preventing human papillomavirus (HPV) vaccine, even though some slow progress has been made, federal researchers report. Four out of 10 girls and six out of 10 boys, aged 13 to 17, have not started the recommended HPV vaccine series, leaving them vulnerable to developing a wide array of cancers, according to the U.S. Centers for Disease Control and Prevention. Every year, about 27,000 women and men in the United States are diagnosed with a cancer caused by HPV infection, the CDC said. HPV vaccination could prevent the majority of these cancers from ever developing, said Dr. Anne Schuchat, assistant surgeon general and director of CDC's National Center for Immunization and Respiratory Diseases. Nearly all cervical and anal cancers are caused by HPV, ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Gardasil 9

Despite Benefits, Few U.S. States Mandate Cervical Cancer Vaccine

Posted 14 Jul 2015 by Drugs.com

TUESDAY, July 14, 2015 – Almost a decade after the HPV vaccine was first recommended for girls, only two U.S. states and Washington, D.C., require the immunization, a new study finds. What's more, researchers say, most U.S. states do require other vaccines routinely recommended for preteens and teenagers – the vaccines against hepatitis B, chickenpox and meningitis. "Our study can't answer the question of why," said Jason Schwartz, a bioethics researcher at Princeton University in New Jersey. "We can only show that there's a stark difference between HPV and these other vaccines." But Schwartz speculated that states may not want to revisit the controversy that arose with HPV vaccine approval in 2006. At the time, numerous states did propose legislation to require the vaccine. But that drew opposition from wary parents and even public health experts, who said it was too soon for ... Read more

Related support groups: Human Papilloma Virus, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis

HPV Vaccination Tied to Drop in Precancerous Cervical Lesions in U.S.

Posted 22 Jun 2015 by Drugs.com

MONDAY, June 22, 2015 – A new study offers more evidence that the advent of vaccines to fight human papillomavirus (HPV) could reduce cervical cancer in American women. While it's still too early to say that vaccines such as Gardasil and Cervarix are lowering cases of cervical cancer, the new study finds a recent decline in the number of young American women with cervical tissue changes that can lead to cancer. However, researchers led by Susan Hariri of the U.S. Centers for Disease Control and Prevention stressed that another factor may be driving the trend: changes made to cervical cancer screening recommendations in recent years. "We think that the decreases in high-grade [precancerous] lesions in this group reflect changes in screening but also may be partially due to HPV vaccination," Hariri said in a news release from the journal Cancer, which published the results of the new ... Read more

Related support groups: Human Papilloma Virus, Gardasil, Cervarix, Cervical Dysplasia, Human Papillomavirus Prophylaxis

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Human Papilloma Virus